![Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN](https://media.cnn.com/api/v1/images/stellar/prod/211230154406-teva-pharmaceuticals-file-2021.jpg?q=h_1332,w_2000,x_0,y_0)
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
![Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA](https://www.fda.gov/files/styles/recall_image_small/public/2_12.jpg?itok=TE3Ci_G3)
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
![Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News](https://s.abcnews.com/images/US/teva-pharma-2-gty-ps-221103_1667481193658_hpMain_16x9_1600.jpg)
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg?download=1)
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
![Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/Inhaler.png)
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development
![Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions](https://s40123.pcdn.co/wp-content/uploads/2022/03/recallTeva-700x547.jpg)